Atlas Trials

Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2)

Clinical trial NCT05244330 · COMPLETED

Trial details

NCT number
NCT05244330
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
COMPLETED
Study type
OBSERVATIONAL
SARS CoV 2 Infection
Start date
2021-12-15
Primary completion
2022-01-15
Enrollment
1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.